Devices › Device types
FDA product code LGW · class 3 · Unknown
Stimulator, spinal-cord, totally implanted for pain relief: medical device reports filed with FDA
378,355 reports carry this product code, 1992–2026; 30 brands with a page.
- 378,355
- reports with this product code
- 1.5% of all MAUDE reports
- 31,154
- reports, 12 months to August 2026
- 31,416 in the 12 months before
- 27.3%
- classified as malfunction
- 62.3% across all reports
- 0.5%
- classified as death, as reported
- 0.9% across all reports
Product code LGW is FDA's classification for "Stimulator, spinal-cord, totally implanted for pain relief" (unknown panel), a class 3 device. 378,355 medical device reports carry this product code, 1.5% of the MAUDE database, from September 1992 to August 2026.
31,154 reports arrived in the 12 months to August 2026, close to the 31,416 of the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (72%), malfunction (27.3%) and death (0.5%). 30 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands with this product code
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Manufacturers named
| Manufacturer (as written on reports) | Reports | Share |
|---|---|---|
| Boston Scientific Neuromodulation | 78,568 | 20.8% |
| Medtronic Puerto Rico Operations | 78,336 | 20.7% |
| St Jude Medical - Neuromodulation Puerto Rico | 59,725 | 15.8% |
| St Jude Medical - Neuromodulation | 56,111 | 14.8% |
| Medtronic Med Rel Medtronic Puerto Rico | 33,763 | 8.9% |
| Abbott Medical | 26,317 | 7% |
| Medtronic Neuromodulation | 13,746 | 3.6% |
| Nevro | 6,606 | 1.7% |
| Mdt Puerto Rico Operations Juncos | 4,460 | 1.2% |
| Advanced Neuromodulation Systems | 2,989 | 0.8% |
| Mdt Puerto Rico Operations | 1,842 | 0.5% |
| Saluda Medical | 1,613 | 0.4% |
| Mdt Sofamor Danek Puerto Rico Mfg | 1,314 | 0.3% |
| St Jude Medical Neuromodulation | 1,209 | 0.3% |
| St Jude Medical - Neuromodulation Division | 1,129 | 0.3% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type and report source
Event type
Who filed
Grey bar: all 26,136,888 MAUDE reports.
Device problems coded
| Device problem (FDA code) | Reports | Share |
|---|---|---|
| Charging problem | 42,504 | 11.2% |
| High impedance | 36,660 | 9.7% |
| Battery problema problem with the battery | 29,360 | 7.8% |
| Device operates differently than expectedthe device behaved unexpectedly | 28,407 | 7.5% |
| Insufficient device problem information | 25,875 | 6.8% |
| Migrationthe device moved from where it was placed | 21,536 | 5.7% |
| Communication or transmission problemthe device could not communicate or transmit | 18,877 | 5% |
| Migration or expulsion of device | 17,740 | 4.7% |
| Failure to deliver energy | 16,623 | 4.4% |
| Unexpected therapeutic results | 16,260 | 4.3% |
| Inappropriate/inadequate shock/stimulation | 13,946 | 3.7% |
| Therapeutic or diagnostic output failure | 13,249 | 3.5% |
| Overheating of device | 13,078 | 3.5% |
| Wireless communication problema wireless connection problem | 12,825 | 3.4% |
| Improper or incorrect procedure or method | 9,864 | 2.6% |
| Failure to interrogate | 8,494 | 2.2% |
| Energy output problem | 7,373 | 1.9% |
| Impedance problem | 7,324 | 1.9% |
| Unintended collision | 7,031 | 1.9% |
| Fracturea broken bone | 6,875 | 1.8% |
Questions about stimulator, spinal-cord, totally implanted for pain relief reports
What is product code LGW?
FDA's classification code for "Stimulator, spinal-cord, totally implanted for pain relief", class 3, reviewed by the unknown panel. Every device report carries the product code of the device involved.
How many reports carry this code?
378,355 reports through August 2026, 31,154 of them in the latest 12 months.
Which brands appear most often?
Intellis (42,024), Octrode Lead Kit, 60cm Length (37,681), SureScan (32,332), Precision? (25,905) and Proclaim 5 Elite Implantable Pulse Generator (20,813). Widely used products collect more reports because more people use them.
Can the brands table be used to rank the devices?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.